禪遊科技(02660.HK)因監管變動控股股東終止承諾
禪遊科技(02660.HK)公布,鑑於2020年1月1日生效的外商投資法終稿,公司獲中國法律顧問告知,原應支撐公司對承諾需求的相關中國法律草案不再相關,此外聯交所已就終止承諾授出同意,承諾於2020年7月3日終止。
公司申請於聯交所上市期間,曾獲中國法律顧問告知倘2015年外國投資法(草案)的條文在外商投資法終稿中被採納,公司架構合約可能被視為境內投資,首席執行官葉升及首席技術官楊民均為中國國籍,為申請架構合約被視為境內投資之目的,其各自承諾在持有公司控股權益期間始終保持中國國籍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.